These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33093461)

  • 21. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling.
    Ling J; Wang F; Liu C; Dong X; Xue Y; Jia X; Song W; Li Q
    J Exp Clin Cancer Res; 2019 Apr; 38(1):179. PubMed ID: 31027497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation.
    Tan MK; Lim HJ; Harper JW
    Mol Cell Biol; 2011 Sep; 31(18):3687-99. PubMed ID: 21768309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy.
    Cui SZ; Lei ZY; Guan TP; Fan LL; Li YQ; Geng XY; Fu DX; Jiang HW; Xu SH
    Cancer Sci; 2020 May; 111(5):1567-1581. PubMed ID: 32133742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic insights into KDM4A driven genomic instability.
    Young NL; Dere R
    Biochem Soc Trans; 2021 Feb; 49(1):93-105. PubMed ID: 33492339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM).
    Lapidot M; Case AE; Weisberg EL; Meng C; Walker SR; Garg S; Ni W; Podar K; Hung YP; Carrasco RD; Knott A; Gokhale PC; Sharma S; Pozhitkov A; Kulkarni P; Frank DA; Salgia R; Griffin JD; Saladi SV; Bueno R; Sattler M
    Br J Cancer; 2021 Aug; 125(4):582-592. PubMed ID: 34088988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
    Tzatsos A; Paskaleva P; Ferrari F; Deshpande V; Stoykova S; Contino G; Wong KK; Lan F; Trojer P; Park PJ; Bardeesy N
    J Clin Invest; 2013 Feb; 123(2):727-39. PubMed ID: 23321669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of PKF118-310 as a KDM4A inhibitor.
    Franci G; Sarno F; Nebbioso A; Altucci L
    Epigenetics; 2017 Mar; 12(3):198-205. PubMed ID: 27767379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth.
    Sun Y; Xie J; Cai S; Wang Q; Feng Z; Li Y; Lu JJ; Chen W; Ye Z
    Cell Death Dis; 2021 Oct; 12(10):913. PubMed ID: 34615858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2
    Bhan A; Ansari KI; Chen MY; Jandial R
    Cancer Res; 2021 Jun; 81(12):3200-3214. PubMed ID: 33941612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response in pancreatic cancer.
    Huang C; Zhou S; Zhang C; Jin Y; Xu G; Zhou L; Ding G; Pang T; Jia S; Cao L
    Cancer Lett; 2022 Apr; 530():16-28. PubMed ID: 35033590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation.
    Liu YW; Xia R; Lu K; Xie M; Yang F; Sun M; De W; Wang C; Ji G
    Mol Cancer; 2017 Feb; 16(1):39. PubMed ID: 28209170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lysine demethylase KDM4A controls the cell-cycle expression of replicative canonical histone genes.
    Van Rechem C; Ji F; Mishra S; Chakraborty D; Murphy SE; Dillingham ME; Sadreyev RI; Whetstine JR
    Biochim Biophys Acta Gene Regul Mech; 2020 Oct; 1863(10):194624. PubMed ID: 32798738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HP1a/KDM4A is involved in the autoregulatory loop of the oncogene gene c-Jun.
    Liu Y; Zhang D
    Epigenetics; 2015; 10(6):453-9. PubMed ID: 25945750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539.
    Nai Y; Pan C; Hu X; Ma Y
    Cancer Med; 2020 Jan; 9(2):757-767. PubMed ID: 31789465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer.
    Kong Y; Li Y; Luo Y; Zhu J; Zheng H; Gao B; Guo X; Li Z; Chen R; Chen C
    Mol Cancer; 2020 May; 19(1):82. PubMed ID: 32366257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.